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Introduction
MicroRNAs (miRNAs) are a recently discovered class of short, non-coding, single stranded RNAs (approximately 22-24 nucleotides), and they function in transcriptional and post-transcriptional regulation of gene expression [1] . Mature miRNAs form part of an active RNA-induced silencing complex (RISC, also called microRNA ribonucleoprotein complex, miRNP) containing Dicer and many associated proteins [2] . This complex acts as a regulator of numerous biological processes by either triggering degradation of the target mRNAs or suppressing their translation through incomplete base-pairing to the 3' untranslated region (3'UTR) [3] . Although the functioning patterns and target genes of most miRNAs are still unknown, diverse miRNAs have recently been reported to participate in processes such as embryogenesis, embryonic development, stem cell pluripotency, differentiation, organogenesis, growth, cell proliferation and apoptosis [4] [5] [6] [7] [8] [9] .
Early embryonic development is a highly complicated process that comprises multitudinous biological events. Epigenetic regulation, considered to be one of the most important mechanisms, plays an important role in early embryonic development. Many studies have revealed that genomic DNA methylation is a dynamic process of reprogramming that mainly includes a wide range of genomic DNA demethylation statuses after fertilization and de novo methylation restored not long after implantation [10] [11] [12] . A previous study suggested that several miRNAs affect mouse embryonic development via DNA methylation during the morula to blastocyst transition [13] .
In our previous study, miR29b was identified in mouse early embryos through miRNA microarray analysis (data not shown). Biological databases suggest that miR29b is highly conserved in evolution. To date, few studies have examined the role of miR29b in early embryonic development, although there are many reports that miR29b plays a role in DNA methylation by regulating Dnmt3a/3b expression [14] [15] [16] . In the present study, the expression patterns of miR29b and Dnmt3a/3b were analyzed in mouse early embryos at different stages, and the functional exploration of miR29b suggests an important role for miR29b in mouse early embryonic development mediated by miR29b-DNMT3 signaling.
Materials and Methods

Reagents and Animals
Reagents used for in vitro culture were from Sigma Chemicals (St. Louis, MO, USA) unless stated otherwise. All experimental animals (ICR white mice) were maintained in a controlled environment of 20-22°C with 50-70% humidity, 12/12-h light/dark cycle and adequate supply of food and water. Animal care and experimental procedures were conducted in accordance with the Animal Research Committee guidelines of Nanjing Medical University (China).
Embryo Collection and Culture
For zygote collection, 8-week-old female ICR mice were injected intraperitoneally (i.p.) with pregnant mare serum gonadotropin (PMSG; 10 IU) and human chorionic gonadotropin (HCG; 10 IU) 48 h later, followed by mating with male ICR mice. After 15-17 h, zygotes were obtained from the oviducts and placed into Hepes-buffered CZB medium. Cumulus cells were dispersed with 1 mg/ml hyaluronidase in Hepes-CZB. Cumulus-free zygotes were washed with Hepes-CZB medium and then cultured in CZB medium at 37°C in a humidified atmosphere of 5% CO2 until the later stages of early embryos.
Immunofluorescence
Early embryos from zygote to blastocyst stage were fixed in 4% paraformaldehyde (PFA) in phosphatebuffered saline (PBS; pH 7.4) for approximate 30 min at room temperature (RT). After being treated in permeabilization buffer (0.5% Triton X-100 in 20 mM Hepes [pH 7.4], 3 mM MgCl2, 50 mM NaCl, 300 mM sucrose, and 0.02% NaN3) for 30 min at 37℃, the embryos were blocked in 1% bovine serum albumin [17] [18] [19] . The same parameters were used for microscopic analysis of the experimental and control groups.
RNA (miRNA/mRNA) Isolation and Real-Time PCR
Total RNA, including miRNAs and other small RNAs, was purified from early developmental stage embryos using a miRNeasy Mini Kit (Qiagen, 217004) according to the manufacturer's protocol. The cDNAs were reverse transcribed from total RNA samples using miR29b-specific, stem-loop RT primer from the TaqMan® Small RNA Assays (Applied Biosystems, 4427975) and reagents from the TaqMan® MicroRNA Reverse Transcription Kit (Applied Biosystems, 4366596). Real-time PCR analysis was carried out using TaqMan® Universal Master Mix (Applied Biosystems, 4324018) using U6 snRNA as an endogenous control.
Otherwise, total RNA from early developmental stage embryos was extracted using the RNeasy Micro Kit (Qiagen, 74034). Real-time PCR analysis was carried out using SYBR ® Premix EX Taq (Takara, DRR420A), and the gapdh gene acted as an internal control. The primer sequences used in the real-time PCR analysis were as follows:
dnmt3a ( The experiments were repeated at least three times.
Microinjection of miR29b Inhibitor or Mimic into Zygotes
The mirVana® miRNA Inhibitor (Applied Biosystems, 4464084) or mirVana® miRNA Mimic (Applied Biosystems, 4464066) specific for mmu-miR29b (mouse miR29b) was microinjected into the cytoplasm of zygotes as described previously [20] , and the mirVana® miRNA Inhibitor Negative Control #1 (Applied Biosystems, 4464084) or mirVana® miRNA Mimic Negative Control #1(Applied Biosystems, 4464066) was used as the relevant negative control. These reagents (approximately 5-7 µl per zygote) were microinjected at 100 nM, while non-injected zygotes served as the normal control groups. A Nikon Diaphot ECLIPSE TE 300 inverted microscope (Nikon, Yuko, Japan), equipped with Narishige MM0-202N hydraulic three-dimensional micromanipulators (Narishige Inc., Tokyo, Japan) was used for these experiments. After microinjection, the zygotes were washed and cultured in CZB medium for observation of further embryonic development or collected to determine Dnmt3a/3b expression. relatively low level thereafter (Fig. 1A) . Meanwhile, the mRNA expression levels of both Dnmt3a and Dnmt3b mRNA increased significantly from the 4-cell stage (Fig. 1B, 1C) , although Dnmt3a reverted to a low level at the blastocyst stage (Fig. 1B) , while Dnmt3b was maintained at a relatively high level in subsequent stages until the blastocyst stage (Fig. 1C) . These results confirmed the expression of miR29b and Dnmt3a/3b in mouse early embryos. It is noteworthy that Dnmt3a/3b expression levels exhibited an inverse correlation with miR29b, which suggested that these molecules are targets of miR29b and are negatively regulated by miR29b in mouse early embryos.
Localization of DNMT3A/3B in Mouse Early Embryos
The dynamic distribution of DNMT3A/3B proteins from the zygote to blastocyst stage is shown in Fig. 2 . Immunofluorescence staining of DNMT3A/3B was observed predominantly in the nucleoplasm of embryos. As with the mRNA expression, there were differences between the expression of DNMT3A and DNMT3B proteins in the early embryo stages. DNMT3A protein expression decreased obviously in the morula stage, with almost no signal detected in the blastocyst stage ( Fig. 2A) , while DNMT3B was expressed persistently until the blastocyst stage, with expression increasing from the morula stage to the blastocyst stage (Fig. 2B) . No significant differences were observed in the signals detected in the negative control (rabbit IgG) group at all stages of mouse early embryo development. 
Alterations in miR29bActivity in Mouse Early Embryos
MiR29b regulates Dnmt3a/3bexpression in mouse early embryos. Dnmt3a/3b mRNA expression levels were detected using real-time PCR. Dnmt3a/3b mRNA expression increased markedly in miR29b inhibitor-injected embryos (collected from the 4-cell to blastocyst stage) compared with those in the negative control inhibitor-injected or non-injected embryos (Fig.  3A, 3C) . In contrast to the effects of miR29b inhibition, both Dnmt3a and Dnmt3b mRNA levels decreased distinctly in miR29b-mimic-injected embryos (collected from the 4-cell to blastocyst stage) compared with those in the negative control mimic-injected or noninjected embryos (Fig. 3B, 3D ). These results revealed that Dnmt3a/3b expression levels were regulated by miR29b in mouse early embryos.
Alterations in miR29b activity lead to early embryonic developmental blockade. To investigate the function of miR29b in mouse early embryonic development, a specific miR29b inhibitor or mimic was used to alter its activity in mouse early embryos. A remarkable block were observed from the morula stage (Day 3.5) to the blastocyst stage (Day 4.5) as a result of down-regulated miR29b activity, with only 50% to 60% of embryos progressing to the blastocyst stage compared to the negative and non-injected groups ( Fig. 4A; Fig. 5A ). Intriguingly, a similar phenotype observed in the miR29b mimic-injected groups compared with the negative and non-injected groups from the morula to the blastocyst stage ( Fig. 4B;  Fig. 5B ), which suggested that up-regulation of miR29b also resulted in early embryonic developmental hysteresis in mouse. To access whether DNA methylation is affected by alterations in miR29b activity, we detected 5mc signal using immunofluorescence.
Interestingly, we find that mimic group significantly reduce DNA methylation level, but inhibitor group obviously increase DNA methylation level (Fig. 6) . In summary, alterations Only 50-60% of morula embryos progressed to the blastocyst stage compared with the rate observed in the negative and non-injected groups. (B) Up-regulation of miR29b by microinjection of an effective miR29b mimic also caused early embryonic developmental hysteresis. More than 50% of embryos failed to develop to the blastocyst stage, in comparison with the negative and non-injected groups. Data represent the mean ± SD; *P < 0.01. Zhang 
in miR29b activity can cause to DNA methylation disorder and lead to early embryonic developmental blockade by regulating expression of DNMT3a/b. Functional analysis of miR29b revealed that miR29b activity influenced mouse early embryonic development.
Discussion
MiRNAs are small, non-coding RNAs that regulate the expression of many genes. Recent studies suggest that miRNAs could play crucial roles in the maternal-to-embryonic transition (MET), as expression profiles indicate a potential regulatory role during early developmental 6 . Immunofluorescence of 5-methylcytosine (5-mC) at the morula stage. Embryos were treated with a miR29b inhibitor or mimic and collected at the morula stage. Compared with the negative control and normal group, the 5-mC signal was significantly reduced in the mimic group but was noticeably increased in the inhibitor group. [21] . In previous studies, the miR29b gene was shown to be up-regulated in 2-cell embryos and was expressed at significantly reduced levels in developmentally retarded embryos compared with those in normal embryos. These results indicated that miR29b plays an important role in the process of embryonic development. DNA methylation is widespread in most species and is crucial for gene expression and embryogenesis. Previous studies have shown that miR29 expression is inversely correlated to Dnmt3a/3b expression. The enforced expression of miR29s in lung cancer cell lines restores normal patterns of DNA methylation, induces re-expression of methylation-silenced tumor suppressor genes and inhibits tumorigenicity both in vitro and in vivo [22] . Current studies show that overexpression of miR29b in acute myeloid leukemia cells results in marked reduction in the expression of the DNA methyltransferases, DNMT1, DNMT3A and DNMT3B, at both the RNA and protein levels [23] .
In the present study, we first characterized the role of miR29b in the regulation of DNA methylation during early embryo development in the mouse. Our data showed upregulation of miR29b in the 2-cell embryos, with low expression levels maintained during the period from the 4-cell embryo stage to the blastocyst stage. In contrast, the expression of Dnmt3a and Dnmt3b were upregulated from the 4-cell embryo stage, with high expression levels maintained through later time points. Immunofluorescence studies showed that the expression of DNMT3A and DNMT3B proteins reflected a similar pattern to that observed for Dnmt3a and Dnmt3b mRNA expression. These results are consistent with previous reports. Until this work, the function and mechanisms of miR29b in the process of preimplantation embryonic development had not been reported. Additionally, we used knock-down and over-expression experiments to further study the functional role and potential molecular mechanisms of mir29b in the process of embryonic development. According to a previous report, the loss of DNMTs leads to a phenotype that includes developmental arrest or death of the pups shortly after birth, due to DNA hypomethylation [24] . Our study showed that up-regulation of miR29b resulted in a marked reduction of the expression of Dnmt3a and Dnmt3b at the mRNA level and DNA hypomethylation in the embryo. Conversely, DNA methylation could contribute to gene silencing [25] . DNA hypermethylation might inhibit some of the genes which are involved in embryo development. Although the loci of DNA methylation, and the genes involved in this process, are still unknown, our data suggest that homeostasis of DNA methylation is related to embryo development. Taken together, miR29b may contribute to disruption of DNA methylation by regulating expression of DNMT3a/b, which leads to early embryonic developmental blockade. These results further validate that miR29b plays an important role in the development of early embryos through regulating the expression of the Dnmt3a/Dnmt3b gene. In addition, our results suggest that precise methylation regulation is essential for mouse early embryonic development.
Using various experimental methods, certain miRNAs were continuously reported in recent studies in the field of animal embryogenesis [26] [27] [28] [29] [30] . During the implantation period, potential regulators of endometrial receptivity include miRNAs [31] . These findings all indicate that miRNAs play a critical role in embryo development. During mammalian development, the methylation patterns required for genomic imprinting change dynamically. DNA methylation, including maintenance methylation and de novo methylation directed by DNA methyltransferases (DNMTs), is important for embryo development. Abnormal function of these DNMTs may have serious consequences for embryonic development, such as inhibition of DNA methylation maintenance, leading to a decreased implantation rate of embryos, increased fetal absorption, and poor fetal and placental development [32] . In summary, our data suggest that miR29b takes part in the development of mouse preimplantation embryos by regulating the expression of DNMT3A and DNMT3B. These results represent a theoretical basis for clarification of the mechanisms underlying the regulation of embryonic development.
